The Impact of Covid-19 Pandemic on the Detection of Tuberculosis in Armenia
The Impact of Covid-19 Pandemic on the Detection of Tuberculosis in Armenia作者机构:National Center of Pulmonology Abovyan Armenia Data Management and Monitoring Department National Center of Pulmonology Abovyan Armenia Medical Affairs of the National Center for Pulmonology Abovyan Armenia
出 版 物:《Journal of Tuberculosis Research》 (结核病研究(英文))
年 卷 期:2022年第10卷第4期
页 面:199-204页
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
主 题:Tuberculosis Covid-19 Pandemic Detection of Tuberculosis
摘 要:Background: One of the vulnerable components of Tuberculosis Care Programs affected by the Covid-19 pandemic was the detection of tuberculosis (TB). Based on this conviction, a study devoted to the impact of the Covid-19 pandemic on the detection and diagnosis of tuberculosis was conducted in Armenia. Methods: This observational study has a retrospective descriptive research design based on the comparative calculation of the TB incidence rate for the historical pre-pandemic period (01-Mar-2019 to 29-Feb-2020) and during the Covid-19 pandemic period (01-Mar-2020 to 28-Feb-2021). Results: The data evaluation revealed that the number of active TB cases detected during the Covid-19 pandemic was lower by 37.6% compared with the pre-pandemic period (416 vs. 667). The significant reduction of the bacteriologically confirmed cases of pulmonary tuberculosis (28% drop) was most likely related to the decrease in the sputum diagnostic tests, as the number of patients who were tested by sputum microscopy during the pandemic was lower by 43.3% compared with the pre-pandemic period (2329 vs. 4110) and the number of patients tested by sputum GeneXpert test dropped by 23% during the Covid-19 pandemic (2291 vs. 2977). Conclusion: The comparative calculation of TB detection rate changes during the Covid-19 pandemic revealed a significant decrease in TB detection compared with the pre-pandemic period. The probable reasons for this decrease were the restrictions on visits to medical centers, limited access to diagnostic services, and undermined screening and contact tracing activities.